XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings per Common Share
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Earnings per Common Share Earnings per Common Share
Basic earnings per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per common share adjusts basic earnings per common share for the effects of potentially dilutive common shares. Potentially dilutive common shares include the dilutive effects of shares issuable upon exercise or vesting of outstanding awards under our equity compensation plans, including stock options and share-based awards (restricted share awards, restricted stock units and performance stock units), each using the treasury stock method.
For the three and nine months ended September 30, 2023, we used the if-converted method for calculating the potential dilutive effect of the conversion feature of the principal amount of our 2.0% convertible senior notes due 2023 (“2023 Convertible Notes”) on earnings per common share. The conversion feature had a dilutive impact on earnings per common share for the three and nine months ended September 30, 2023, as the average market price per share of our common stock for the period exceeded the conversion price of $101.38 per share. During the three and nine months ended September 30, 2024, there were no 2023 Convertible Notes outstanding.
 Three Months Ended September 30,Nine Months Ended September 30,
 2024202320242023
Numerator — basic and diluted    
Net income$66,466 $83,317 $230,378 $193,259 
Denominator
Weighted average number of common shares outstanding — basic
35,315 34,128 35,172 33,599 
Effect of dilutive share-based awards521 515 527 547 
Effect of dilutive stock options56 285 143 296 
Effect of dilutive convertible notes— 728 — 1,157 
Weighted average number of common shares outstanding — diluted
35,892 35,656 35,842 35,599 
Earnings per common share — basic$1.88 $2.44 $6.55 $5.75 
Earnings per common share — diluted$1.85 $2.34 $6.43 $5.43 
Antidilutive stock options and share-based awards19 27